Invectys
is a Texas-based clinical-stage biopharmaceutical company that researches and develops immunotherapies for the treatment of cancer... Read moreInvectys
is a Texas-based clinical-stage biopharmaceutical company that researches and develops immunotherapies for the treatment of cancer... Read more
News
Aug 01, 2023
Pharmabiz
Invectys: Invectys' CART cell therapy, IVS3001 receives US FDA fast track designation to treat renal cell carcinoma
Jul 13, 2023
Life Care News
Invectys: Invectys Announces Initiation of Phase 1/2a Clinical Trial
Jan 05, 2023
GlobalNewswire
Press Release: Invectys : INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE ON JANUARY 9-12, 2023
Dec 20, 2022
Life Care News
Invectys: Invectys and CTMC announce FDA clearance of IND application
Jun 22, 2022
Beckers Hospital Review
Invectys: MD Anderson inks strategic collaboration for CAR-T therapy development
Jun 17, 2022
Pharamceutical Technology
Invectys: MD Anderson, Invectys and CTMC partner to develop CAR T cell therapy
Apr 11, 2022
GlobalNewswire
Press Release: Invectys : Invectys, Inc. Appoints Franois Lescure as General Manager of its R&D Subsidiary, Invectys, SAS
Mar 09, 2022
FirstWord Pharma
Invectys: Wayne Marasco joins Invectys' Scientific Advisory Board
Jan 06, 2022
GlobalNewswire
Press Release: Invectys : Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Jan 05, 2022
GlobalNewswire
Press Release: Invectys : INVECTYS INC. TO PARTICIPATE IN THE 2022 JP MORGAN HEALTHCARE MEETING AND BIOTECH SHOWCASE, JANUARY 10-19, 2022
Invectys Competitors
1
2
3
4
5
6
7
8
9
10